Soligenix Investor Overview

(1:37)

Soligenix; An Introduction to Christopher J. Schaber

(9:1econd)

Soligenix Investor Overview

(2:8)

\

(8:55)

Soligenix; Announcing New FDA Drug Application Submission for Cutaneous T-cell Lymphoma

(5:37)

Soligenix, Inc - Superlative Performance in Rare Diseases

(34:41)

Soligenix, Inc.'s interview with Dr. Christopher J. Schaber, Chairman, President, and CEO

(8:55)

Soligenix; Importance of the Proposed Reverse Stock Split

(5:34)

Soligenix; An Introduction to Chief Scientific Officer Dr. Oreola Donini

(6:22)

Soligenix's (NASDAQ:SNGX) Breakthrough Therapies for Rare Diseases – Corporate Update

(7:55)

Soligenix; An Introduction to Senior Vice President and CFO Jonathan Guarino

(7:59)

Soligenix; Discussing the Benefits of HyBryte™ CTCL Treatment with Michael W. Young

(13:31)

Soligenix ; FDA Awards $2.6 Million Orphan Products Development Grant for Expanded Study of HyBryte™

(3:4)

Soligenix, Inc. (NASDAQ: SNGX)

(32:45)

Soligenix; Discussing Psoriasis Treatment with Dr. Neal Bhatia

(6:47)

Soligenix; Receives US Patent Allowance for Thermal Stabilized Vaccine Platform

(2:56)

The MOST FUN Tactic I Have Used in FC 25 || 4141🔥

(6:15)

Cramer's Mad Dash: Moderna gets upgrade from HSBC

(50)

Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau

(3:11)

Investor Watch: Soligenix, Inc Stock Analysis \u0026 Price Predictions for Thursday

(11:11)

Soligenix CEO Dr.Christopher Schaber on Ricin poisoning \u0026 Soligenix's RiVax™

(2:32)

Revolutionizing Rare Disease Treatment: Soligenix's Breakthroughs

(6:31)